News

SDC Showcases AI Innovation at SCOPE Summit 2026 - SDC Clinical

Gillian Dellacioppa — Tue, 27 Jan 2026 15:42:58 GMT

Empowering Clinical Research: SDC’s Sidekick™ AI Sets a New Standard
for Intelligent Oversight

SDC Launches SDC Insights with Sidekick™ — Ushering in a New Era of AI-Native Clinical Trial Oversight - SDC Clinical

Jennifer Royle-Jones — Thu, 25 Sep 2025 14:50:32 GMT

Built from the ground up as an AI-native platform, SDC Insights with Sidekick enables predictive, transparent, and transformative oversight — delivering the future of clinical research today.

Tempe, AZ – September 25, 2025 –

SDC Clinical, a leader in biometrics and clinical data management and technology solutions, today announced the launch of SDC Insights 2.0 with Sidekick™ AI. Unlike competitors that market AI as an add-on or feature, SDC Sidekick is built as an AI-native clinical trial oversight platform, enabling sponsors and CROs to execute risk-based monitoring, predictive analytics, and regulatory compliance with precision and speed.

Across the life sciences industry, executive leadership has put forward a clear mandate: embed AI into core operations. The challenge? Many platforms offer “AI features” but lack the transparency, scalability, data protections and regulatory readiness required for true adoption for clinical trials.

Sidekick by SDC changes that. It provides real-time, explainable and actionable oversight across EDC, CTMS, IRT, labs, ePRO, wearables, and so much more — backed by SOC 2, ISO 27001, and 21 CFR Part 11 compliance.

What sets SDC apart: Sidekick AI’s priority validation protocol. With a one-click “verify” button, clients can confirm the accuracy of their query results within hours — ensuring immediate answers, reusable validations, and lasting confidence in their oversight decisions. No other provider offers this level of assurance.

Unlike traditional tools, SDC Sidekick is already demonstrating measurable outcomes:

23% reduction in site-monitor visits within 90 days in oncology studies.
12 critical adverse events flagged within hours and days earlier earlier than manual reviews.
Streamlines data reporting process, saving CRAs 4+ hours per week.
Answers to your key questions within seconds
100% mock audit pass rate, supported by row-level traceability and hot-key validation.
Deployment in ≤30 days, often before First Patient In.

“Our industry is at a turning point,” said Faith Kolb, President and COO, SDC. “The future of life sciences won’t be defined by incremental efficiencies, but by how confidently we harness AI to protect patients, accelerate development, and prove compliance. With SDC Insights and Sidekick, we’ve built an AI-native oversight platform that delivers on that promise today. And with our built-in validation protocol, clients can simply push a button to confirm their results in hours — confidence no other provider can match. This is the new era of clinical research: oversight that is timely, predictive, transparent, and transformative.”

SDC Sidekick is designed to meet the needs of diverse stakeholders across the trial ecosystem:

Clinical Operations Executives: Monitor and mitigate risk days earlier
Biometrics & Data Management: Focus resources with AI-driven query triage and actionable results
CRAs & CTMs: Cut meeting prep by 40% with auto-flagged dashboards for key data
Safety Teams: Identify DLT and SAE clusters in hours, not weeks
Sponsors & Procurement: Achieve ROI in one study phase, with predictable pricing and faster value

C-Suite/Board Level: real-time access to KPIs and Metrics to support strategic level decisions.

“The future of oversight isn’t about adding AI features — it’s about delivering AI-native execution. With SDC Insights and Sidekick, trial teams can mine data for any answer in real time, with the strength of a CDM, biostatistician, safety reviewer, and programmer right at their side. That’s how we protect patients, accelerate therapies, and deliver compliance without compromise.”— Richard Abelson, Founder and CEO, SDC Clinical

About SDC

Since 2005, SDC has partnered with sponsors and CROs worldwide, delivering specialized expertise in biostatistics, data management, AI-enabled oversight, and technology solutions. With over 500 studies supported and 30+ product approvals, SDC combines deep scientific expertise with innovative technology to transform how clinical trials are executed.

About SDC Insights with Sidekick
SDC Insights with Sidekick™ is the industry’s first AI-native oversight platform, built to transform how clinical trials are monitored, managed, and delivered. By unifying data from EDC, CTMS, labs, wearables, and more, the platform empowers teams with predictive analytics, explainable AI, and real-time compliance tools. Designed to meet the challenges of ICH E6(R3) and beyond, Insights with Sidekick enables life sciences organizations to shift from reactive monitoring to proactive, transformative oversight that accelerates safer treatments to patients worldwide.

Media Contact:
Jim Townsend
SVP, Business Development
SDC
+1 480-344-5450
jtownsend@sdcclinical.com
www.sdcclinical.com

Digitizing Clinical Roles Without Losing the Human Touch - SDC Clinical

Jennifer Royle-Jones — Tue, 15 Jul 2025 23:38:16 GMT

Presented on July 15, 2025

Webinar On Demand

In a landscape where technology increasingly shapes clinical roles, the recent webinar highlighted the transformative power of artificial intelligence in enhancing the workflows of Clinical Research Associates, data managers, and biostatisticians. By integrating AI, these professionals are experiencing a significant reduction in manual tasks, allowing them to focus on more strategic responsibilities and improve productivity. This shift not only accelerates decision-making processes but also elevates the quality of data being analyzed and utilized. As AI tools continue to evolve, participants learned how to harness these innovations, ensuring that the invaluable human insight remains at the core of clinical research, thus bridging the gap between cutting-edge technology and essential human expertise.

Presented By:

Quan Doan – VP of Technology Solutions at SDC

Driving Smarter Decisions with AI-Powered Trial Oversight - SDC Clinical

Jennifer Royle-Jones — Tue, 03 Jun 2025 23:27:28 GMT

Presented on June 3, 2025

Webinar On Demand

In this webinar, we delved into the dynamic world of predictive analytics and its powerful role in enhancing clinical trial management. Participants discovered how trial teams have successfully harnessed artificial intelligence to tackle some of the most pressing challenges in the field. From optimizing enrollment processes that streamline participant recruitment to cutting down on site monitoring costs, the insights shared were both practical and innovative. Additionally, we highlighted strategies that improve trial close-out timing, demonstrating how data-driven decisions can lead to quicker and more efficient outcomes. This session was not just theoretical; it provided attendees with actionable knowledge that can be applied immediately, inspiring a new era of smarter trial management practices.

Presented By:

Quan Doan – VP of Technology Solutions at SDC

Why Data Security is the AI Dealbreaker - SDC Clinical

Jennifer Royle-Jones — Tue, 20 May 2025 23:25:00 GMT

Presented on May 20, 2025

Webinar On Demand

As we navigate the evolving landscape of artificial intelligence, understanding the critical balance between innovation and data security has never been more vital. This enlightening discussion delves into the nuances of AI technologies and their implications for preserving patient privacy in clinical trials. With a spotlight on the growing need for robust data protection measures, we will examine how choosing the right AI architecture not only meets regulatory standards but also enhances trust among stakeholders in the healthcare ecosystem. Join us to uncover the strategies that lead to safer, more compliant AI implementations, ensuring that your data remains secure in an age where vulnerabilities are all too common.

Presented By:

Quan Doan – VP of Technology Solutions at SDC

Faith Haines Kolb Appointed President and Chief Operating Officer of SDC - SDC Clinical

Jennifer Royle-Jones — Wed, 14 May 2025 20:05:11 GMT

Tempe, AZ – Statistics & Data Corporation (SDC), a leading provider of innovative clinical data solutions, proudly announces the promotion of Faith Haines Kolb to President and Chief Operating Officer. This leadership advancement reflects SDC’s continued trajectory of strategic growth, operational excellence, and dedication to client-centric innovation.

With over two decades of experience in clinical research operations, Faith Kolb has played a pivotal role in shaping SDC’s transformation into a premier partner for life sciences organizations. Since joining SDC more than 8 years ago, she has consistently driven internal alignment, delivery excellence, and scalable infrastructure across functions. Her leadership has strengthened SDC’s operational backbone while positioning the company to meet the evolving needs of its clients in a complex and dynamic clinical research environment.

“Faith’s promotion is a testament to the strength and growing maturity of the broader SDC management team and its continued commitment to ownership of SDC goals and our clients needs. I couldn’t be more excited for the capability this team brings as we look towards the next generation of SDC,” said Richard Abelson, Chief Executive Officer of SDC.

This promotion aligns with SDC’s strategic imperatives, including:

Innovating for Impact: Strengthening our proprietary technologies like SDC Sidekick and integrating closed-loop AI solutions through partnerships such as our recent collaboration with Singular.
Operational Excellence: Streamlining infrastructure and delivery frameworks to support faster study start-up times and increased scalability.
Client-First Culture: Reinforcing a service model that is responsive, proactive, and grounded in scientific rigor.

Faith Kolb shared, “I am honored to take on this new role and lead an organization that is truly redefining clinical data services through both people and technology. We are on an exciting path—our teams are energized, our systems are advancing, and our client partnerships are thriving. I look forward to deepening our impact across the industry.”

As SDC continues its growth across North America and global markets, Faith’s leadership will be instrumental in realizing the company’s bold vision for the future of clinical research support services.

About SDC

SDC is a technology-enabled clinical data services provider that delivers scientific expertise, operational excellence, and secure, AI-enhanced platforms to the life sciences industry. With a mission to accelerate study timelines while upholding data integrity and regulatory compliance, SDC is the trusted partner for sponsors navigating complex clinical research landscapes.

Visit https://bit.ly/4jVO9jo to learn more.

Media Contact:
Jim Townsend
SVP, Business Development
SDC
+1 480-344-5450
jtownsend@sdcclinical.com
www.sdcclinical.com

SDC Partners with Singular to Advance Secure AI Solutions in Healthcare - SDC Clinical

Jennifer Royle-Jones — Thu, 30 Jan 2025 19:35:31 GMT

The collaboration introduces innovative AI technology while ensuring data security and the data you want and actionable insights you need at your fingertips.

Tempe, AZ – SDC has partnered with Singular exclusively to integrate secure closed-loop AI capabilities into clinical research technology offerings. This initiative provides the tools to leverage the full power of artificial intelligence while maintaining the security and integrity of study, customer and patient data.

“Singular’s technology enhances our ability to continue to deliver secure and efficient solutions, while also integrating an exclusive AI platform designed specifically for SDC customers,” said Richard Abelson, CEO of SDC. “The SDC Sidekick will simplify how study personnel interact with their data, providing Clinical Research professionals with clearer insights into their trials and improved visibility into emerging trends.”

Unlike external AI tools that may expose sensitive data to third-party risks, the embedded AI solutions developed through this partnership will remain fully integrated within SDC’s ecosystem. This ensures unmatched levels of confidentiality, compliance with stringent data protection regulations, and enhanced operational efficiency for clinical research studies.

“Our collaboration with SDC exemplifies how AI can drive impactful change while maintaining the utmost standards of privacy and trust,” said Uday Chandra, CEO of Singular. “Together, we’re pioneering a new era of secure and efficient research technology.”

Key Benefits of AI-enabled Technology:

Secure Data: Minimizes breaches with closed-loop AI.
Improved Outcomes: Streamlines decision-making for better care.
Optimize Resources: Automating processes, faster analysis, and actionable insights.
Faster Trials: Reduces timelines by 30%.

About SDC

SDC is a leading provider of innovative healthcare technology solutions, dedicated to improving patient outcomes through secure, efficient systems. With a focus on leveraging cutting-edge technology to address the evolving needs of healthcare providers, SDC is at the forefront of industry advancements.

About Singular

Singular is a pioneer in artificial intelligence technology, specializing in secure, closed-loop systems for the healthcare and life sciences sectors. Singular’s mission is to enable organizations to harness the transformative power of AI while maintaining the highest standards of data privacy and trust.

Media Contact:
Jim Townsend
SVP, Business Development
SDC
+1 480-344-5450
jtownsend@sdcclinical.com
www.sdcclinical.com

Visit www.sdclinical.com or https://singlr.ai/ for more information.

SDC Capture Revolutionizes Clinical Trials with new BYOD ePRO Solution - SDC Clinical

Jennifer Royle-Jones — Wed, 28 Aug 2024 20:45:07 GMT

Phoenix, AZ – Statistics & Data Corporation (SDC), a global leader in life sciences
biometrics services and technology solutions, announces the launch of its
groundbreaking Bring Your Own Device (BYOD) electronic Patient Reported Outcomes (ePRO) solution, designed to transform the way clinical trials are conducted.

This cost-efficient state-of-the-art platform is designed to completely eliminate paper from the clinical trial process. In an era where flexibility and efficiency are paramount, SDC Capture’s BYOD ePRO solution allows participants to use their personal devices. This paves the way for greater efficiency, recruitment with less patient burden, patient adherence and improved data quality resulting in optimized trials and endpoint realization.

“We are excited to introduce this innovative, cost-efficient solution that meets the
evolving needs of clinical trials,” said Dr. Richard Abelson, CEO of SDC. “Our BYOD
ePRO solution represents a significant advancement in eliminating paper, enhancing participant experience, and optimizing trial efficiency. We are confident it will deliver exceptional results more affordably and efficiently than any other competing technologies”.

Faith Kolb, COO of SDC further added, “SDC Capture BYOD is an integral part of our product growth strategy. We continue to focus our resources and invest effectively in technology development and optimization that will drive the next generation of clinical research solutions.”

SDC Capture’s BYOD ePRO solution is now available for implementation. For more
information on how this cutting-edge technology can enhance your clinical trials and our ongoing initiatives, please visit www.sdcclinical.com.

For media inquiries or further information, please contact:

Nicole Powell
Vice President, Business Development | SDC
+1-480-632-5468 Ext. 326
npowell@sdcclinical.com

About SDC:

Statistics & Data Corporation (SDC) delivers top-tier technology enabled clinical trial services to pharmaceutical, biologic, medical device/diagnostic as well as CRO partners since 2005. With industry leading biometrics (biostatistics, data management, IRT, safety reporting) and integrated technologies (EDC/RTSM, ePRO/eCOA, eSource, data visualizations/warehousing, etc.) at our core, our offerings are fully scalable from strategic consulting through full-service support of your clinical programs. We are committed to providing experienced teams who will take ownership of your needs and are positively engaged in your projects.

SDC Optimizes Focus on Tech-Enabled Biometric Services - SDC Clinical

Adriana Grado — Tue, 05 Mar 2024 16:29:38 GMT

Phoenix, AZ – Statistics & Data Corporation (SDC), a global leader in life sciences biometrics services and technology solutions, announces a strategic decision to enhance focus and efficiency by transitioning its ophthalmic biometric division to its partner Ora, Inc. Since 2005, SDC’s partnership and common ownership with Ora has provided best-in-class clinical trial services in the field of ophthalmology, while allowing SDC to expand its expertise and offerings in other therapeutic areas and technology. During this time, SDC has developed a reputation as an industry leader in providing biometrics services and the deployment of innovative/integrated technologies across the industry.

SDC’s tech-enabled service offering brings to market an AI/ML enabled clinical ecosystem to unify disparate technologies into a single data lake (SDC DataHub™) and a single point of access reporting platform (SDC Insights™), paired with a cost effective mobile ePRO/eCOA Solution (SDC Capture™). This solution gives clients the flexibility they have been looking for to choose the right fit technologies for their clinical trial and not being forced into one eClinical Platform. SDC’s tech-enabled service offerings bring forward more options than ever to right size your trial; eSource, eConsent, ePRO, safety processing, custom workflows, integrated IRT and EDC options, and giving our clients solutions to strengthen oversight and reduce timelines.

SDC’s 18+ years of service expertise give clients, ready to use, fully delivered solutions with the biometrics expertise (Biostatistics, Data Management, IRT, Safety Reporting) necessary to see a trial/program through to completion.

Dr. Richard Abelson, CEO of SDC commented “The transition of our ophthalmic biometric division signifies our unwavering dedication to excellence and innovation in clinical research services and technology solutions. This strategic shift allows SDC to better leverage our core strengths and deliver greater value to our clients and clinical partnerships.”

Faith Kolb, COO of SDC further added, “This strategic move enables us to focus our resources and invest more effectively in technology development and optimization that will drive the next generation of clinical research solutions.”

The transition of the ophthalmic biometric division is being executed seamlessly, without disruption to ongoing projects or client relationships. SDC will continue to provide exceptional service and support to its clients while driving innovation and pushing the boundaries of clinical research technology.

For more information about SDC and its ongoing initiatives, please visit www.sdcclinical.com For media inquiries or further information, please contact:
Nicole Powell
Vice President, Business Development | SDC
+1-480-632-5468 Ext. 326
npowell@sdcclinical.com

About SDC:
Statistics & Data Corporation (SDC) delivers top-tier technology enabled clinical trial services to pharmaceutical, biologic, medical device/diagnostic as well as CRO partners since 2005. With industry leading biometrics (biostatistics, data management, IRT, safety reporting) and integrated technologies (EDC/RTSM, ePRO/eCOA, eSource, data visualizations/warehousing, etc.) at our core, our offerings are fully scalable from strategic consulting through full-service support of your clinical programs. We are committed to providing experienced teams who will take ownership of your needs and are positively engaged in your projects.

About Ora:

Ora, Inc. is the world’s leading full-service ophthalmic clinical research and product development firm. Over the past 40 years, Ora has helped clients earn 45 FDA approvals. Ora supports a wide array of organizations, from startups to global pharmaceutical and device companies, to efficiently and successfully bring their new products from concept to market. Ora’s pre-clinical and clinical models, unique methodologies and regulatory strategies have been refined and proven across thousands of projects both in the US and internationally. Ora brings together the world’s most extensive and experienced network of ophthalmic experts and R&D professionals to maximize the value of new product initiatives. For more information, please visit www.oraclinical.com.

SDC Announces Partnership with CRIO on eSource Initiative - SDC Clinical

Adriana Grado — Tue, 14 Nov 2023 09:14:02 GMT

The CRIO eSource system enables clients to capture data in real-time

Boston – Continuing the momentum of technology solution innovations after its recent release of SDC Insights^TM, SDC is proud to partner with CRIO to bring eSource functionality in-house to better serve clients and their clinical needs.

“With SDC’s in-house developers, we can efficiently meet the individual needs of each protocol with CRIO eSource, a compliant solution that harnesses real-time data to streamline clinical compliance and reduce transcription errors” says Quan Doan, Vice President, Technology Solutions.

“SDC’s desire to embrace a reimagined approach to clinical trial execution is a testament to their focus on providing the best possible outcomes for their customers,” says Jonathan Andrus, CRIO’s President and COO.

SDC’s eSource solution, powered by CRIO, is a comprehensive, 21 CFR Part 11 compliant system that enables staff to capture data in real-time. Functionality includes:

Elimination of 90% of paper while improving data quality by an average of 80%.
Provision of a library of prebuilt source templates and the ability to reduce build timelines, providing a 25% increase in efficiency during development of a new study.
Providing a user-friendly calendar to easily schedule patients within a window, highlighting the target days and flags visits completed outside the window or that need to be scheduled.
24-hour client access to understand the full audit trail and source changes.
Uploading, routing, editing and signing of documents like lab reports, ECG tracings, or patient diaries with real-time signature updates.
Capturing data directly during the course of a study visit with live edit checks, minimizing transcription of data into EDC, reducing monitoring visits and optimizing data management services.

SDC also just launched SDC Capture™ — ePRO technology to ensure an optimized user experience for clients and sites with superior data reliability and robust data security.

For more information about SDC, please visit www.sdcclinical.com For media inquiries or further information, please contact:
Nicole Powell
Vice President, Business Development | SDC
+1-480-632-5468 Ext. 326
npowell@sdcclinical.com

About SDC:

Statistics & Data Corporation (SDC) delivers top-tier clinical trial services to pharmaceutical, biologic, and medical device/diagnostic companies since 2005. We are committed to providing experienced teams who will take ownership of your needs and are positively engaged in your projects. With strategic consulting, biometric services (biostatistics, data management) and technology solutions (EDC, IRT/RTSM, eSource, data analytics/warehousing) expertise at our core, our services are scalable to provide seamless full service clinical trial solutions. Contact us at info@sdcclinical.com

About CRIO

CRIO helps pharma, biotech, research sites, and academic research centers streamline regulatory workflows with one system that enables a single point of data capture. As the leader in eSource technology, CRIO enables remote monitoring and immediate data review with a powerfully integrated eSource/EDC solution. CRIO’s mission is to design and deliver a modern, intuitive, and integrated software platform that reimagines clinical trials for quality, speed, and patient-centricity.